Macquarie Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-28,084
Closed -$5.16M 2700
2021
Q2
$5.16M Buy
28,084
+168
+0.6% +$30.9K ﹤0.01% 1128
2021
Q1
$4.27M Sell
27,916
-107,983
-79% -$16.5M 0.01% 954
2020
Q4
$21.2M Sell
135,899
-4,090
-3% -$639K 0.03% 503
2020
Q3
$16M Buy
139,989
+1,801
+1% +$206K 0.03% 534
2020
Q2
$15.5M Buy
138,188
+7,318
+6% +$821K 0.03% 531
2020
Q1
$11.8M Sell
130,870
-31,788
-20% -$2.85M 0.02% 532
2019
Q4
$17.6M Sell
162,658
-2,520
-2% -$273K 0.03% 547
2019
Q3
$16.2M Sell
165,178
-7,700
-4% -$754K 0.03% 495
2019
Q2
$22.6M Buy
172,878
+15,820
+10% +$2.07M 0.04% 432
2019
Q1
$21.2M Sell
157,058
-24,600
-14% -$3.33M 0.04% 448
2018
Q4
$17.7M Sell
181,658
-6,821
-4% -$664K 0.03% 456
2018
Q3
$26.2M Sell
188,479
-54,200
-22% -$7.53M 0.04% 410
2018
Q2
$30.1M Sell
242,679
-2,670
-1% -$331K 0.05% 386
2018
Q1
$27.3M Buy
245,349
+44,104
+22% +$4.92M 0.05% 390
2017
Q4
$24.2M Buy
201,245
+81,651
+68% +$9.8M 0.04% 431
2017
Q3
$16.8M Sell
119,594
-12,400
-9% -$1.74M 0.03% 488
2017
Q2
$16.1M Buy
131,994
+57,026
+76% +$6.94M 0.03% 495
2017
Q1
$9.09M Sell
74,968
-18,830
-20% -$2.28M 0.02% 628
2016
Q4
$11.5M Buy
93,798
+12,639
+16% +$1.55M 0.02% 578
2016
Q3
$9.95M Sell
81,159
-61,059
-43% -$7.48M 0.02% 600
2016
Q2
$16.6M Buy
142,218
+34,888
+33% +$4.07M 0.02% 609
2016
Q1
$14.9M Buy
107,330
+10,730
+11% +$1.49M 0.03% 436
2015
Q4
$18.4M Sell
96,600
-2,300
-2% -$439K 0.04% 369
2015
Q3
$15.5M Buy
98,900
+7,800
+9% +$1.22M 0.03% 398
2015
Q2
$16.5M Buy
91,100
+16,197
+22% +$2.93M 0.03% 405
2015
Q1
$13M Buy
74,903
+18,003
+32% +$3.12M 0.03% 474
2014
Q4
$10.5M Buy
56,900
+300
+0.5% +$55.5K 0.02% 509
2014
Q3
$9.39M Buy
56,600
+7,500
+15% +$1.24M 0.02% 514
2014
Q2
$7.67M Buy
49,100
+7,500
+18% +$1.17M 0.02% 579
2014
Q1
$6.33M Buy
41,600
+7,600
+22% +$1.16M 0.01% 613
2013
Q4
$4.52M Buy
34,000
+2,600
+8% +$346K 0.01% 663
2013
Q3
$3.65M Sell
31,400
-1,830
-6% -$213K 0.01% 698
2013
Q2
$3.07M Buy
+33,230
New +$3.07M 0.01% 725